Pietro Giusti
Padova, 35131, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 78 publications
Serum amyloid A1 directly engages TLR4/MD-2 to trigger neuroinflammatory signaling in microglia cultures.
Journal: International immunopharmacology
Published: July 18, 2025
Fentanyl enhances immune cell response through TLR4/MD-2 complex.
Journal: Frontiers in pharmacology
Published: July 22, 2024
The Effect of C-Phycocyanin on Microglia Activation Is Mediated by Toll-like Receptor 4.
Journal: International journal of molecular sciences
Published: January 05, 2022
Pre- and Early Post-treatment With Arthrospira platensis (Spirulina) Extract Impedes Lipopolysaccharide-triggered Neuroinflammation in Microglia.
Journal: Frontiers in pharmacology
Published: June 14, 2021
Co-Ultramicronized Palmitoylethanolamide/Luteolin-Induced Oligodendrocyte Precursor Cell Differentiation is Associated With Tyro3 Receptor Upregulation.
Journal: Frontiers in pharmacology
Published: April 20, 2021
Carotenoid Extract Derived from Euglena gracilis Overcomes Lipopolysaccharide-Induced Neuroinflammation in Microglia: Role of NF-κB and Nrf2 Signaling Pathways.
Journal: Molecular neurobiology
Published: October 05, 2020
Editorial: Neuroinflammation and Its Resolution: From Molecular Mechanisms to Therapeutic Perspectives.
Journal: Frontiers in pharmacology
Published: March 06, 2020
Corrigendum: An Inflammation-Centric View of Neurological Disease: Beyond the Neuron.
Journal: Frontiers in cellular neuroscience
Published: December 12, 2019
Pharmacogenomic Characterization in Bipolar Spectrum Disorders.
Journal: Pharmaceutics
Published: November 25, 2019
Current and emerging avenues for Alzheimer's disease drug targets.
Journal: Journal of internal medicine
Published: July 10, 2019
Ciprofloxacin and levofloxacin attenuate microglia inflammatory response via TLR4/NF-kB pathway.
Journal: Journal of neuroinflammation
Published: February 13, 2019
Last Updated: 09/26/2026